These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 10573380)

  • 1. Fecal clearance of alpha1-antitrypsin with lansoprazole can detect protein-losing gastropathy.
    Takeda H; Nishise S; Furukawa M; Nagashima R; Shinzawa H; Takahashi T
    Dig Dis Sci; 1999 Nov; 44(11):2313-8. PubMed ID: 10573380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fecal alpha1-antitrypsin concentrations as a measure of enteric protein loss after modified fontan operations.
    Fujii T; Shimizu T; Takahashi K; Kishiro M; Ohkubo M; Akimoto K; Yamashiro Y
    J Pediatr Gastroenterol Nutr; 2003 Nov; 37(5):577-80. PubMed ID: 14581800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein-losing gastroenteropathy detected by technetium-99m-labeled human serum albumin.
    Takeda H; Takahashi T; Ajitsu S; Ukai K; Saitoh H; Togashi H; Ishikawa M
    Am J Gastroenterol; 1991 Apr; 86(4):450-3. PubMed ID: 2012047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis of protein-losing enteropathy by gastrointestinal clearance of alpha1-antitrypsin.
    Bernier JJ; Florent C; Desmazures C; Aymes C; L'Hirondel C
    Lancet; 1978 Oct; 2(8093):763-4. PubMed ID: 80688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intestinal clearance of alpha 1-antitrypsin. A sensitive method for the detection of protein-losing enteropathy.
    Florent C; L'Hirondel C; Desmazures C; Aymes C; Bernier JJ
    Gastroenterology; 1981 Oct; 81(4):777-80. PubMed ID: 6973500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in pulmonary hyperinflation and bronchial hyperresponsiveness following treatment with lansoprazole in children with cystic fibrosis.
    Hendriks JJ; Kester AD; Donckerwolcke R; Forget PP; Wouters EF
    Pediatr Pulmonol; 2001 Jan; 31(1):59-66. PubMed ID: 11180676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of proton pump inhibitors on thyroid hormone metabolism in rats: a comparison of UDP-glucuronyltransferase induction.
    Masubuchi N; Hakusui H; Okazaki O
    Biochem Pharmacol; 1997 Dec; 54(11):1225-31. PubMed ID: 9416973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Investigation of protein-losing enteropathy in pediatric patients].
    Sierra Salinas C; Vicioso Recio MI; Barco Galvez A; del Rio Mapelli L; Martinez Valverde A
    An Esp Pediatr; 1997 Aug; 47(2):144-50. PubMed ID: 9382345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of 24-hour intragastric pH using four liquid formulations of lansoprazole and omeprazole.
    Sharma VK
    Am J Health Syst Pharm; 1999 Dec; 56(23 Suppl 4):S18-21. PubMed ID: 10597120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enteric protein loss as a marker of intestinal inflammatory activity in Crohn's disease: comparability of enteric clearance and stool concentration of alpha-1-antitrypsin?
    Hundegger K; Stufler M; Karbach U
    Z Gastroenterol; 1992 Oct; 30(10):722-8. PubMed ID: 1441675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Plasma clearance of alpha 1-antitrypsin. A simple method for the study of intestinal protein loss].
    Olmos M; Villafañe V; Mazure P; Pizzolato M; Brizuela J
    Acta Gastroenterol Latinoam; 1985; 15(4):213-9. PubMed ID: 3879863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proton pump inhibitor treatment of patients with gastroesophageal reflux-related chronic cough: a comparison between two different daily doses of lansoprazole.
    Baldi F; Cappiello R; Cavoli C; Ghersi S; Torresan F; Roda E
    World J Gastroenterol; 2006 Jan; 12(1):82-8. PubMed ID: 16440422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics, metabolism and interactions of acid pump inhibitors. Focus on omeprazole, lansoprazole and pantoprazole.
    Andersson T
    Clin Pharmacokinet; 1996 Jul; 31(1):9-28. PubMed ID: 8827397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Giardiasis with protein-losing enteropathy: diagnosis by fecal alpha 1-antitrypsin determination.
    Korman SH; Bar-Oz B; Mandelberg A; Matoth I
    J Pediatr Gastroenterol Nutr; 1990 Feb; 10(2):249-52. PubMed ID: 2303979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proceedings of the 2nd International Colloquium on Proton Pump Inhibitors.
    J Clin Gastroenterol; 1995; 20 Suppl 1():S1-51. PubMed ID: 7673606
    [No Abstract]   [Full Text] [Related]  

  • 16. Fecal alpha1-proteinase inhibitor concentration in dogs receiving long-term nonsteroidal anti-inflammatory drug therapy.
    Murphy KF; German AJ; Ruaux CG; Steiner JM; Williams DA; Hall EJ
    Vet Clin Pathol; 2003; 32(3):136-9. PubMed ID: 12966464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of four lansoprazole dose levels and one dosage regimen of omeprazole on 24-hour intragastric pH in healthy subjects.
    Timmer W; Ripke H; Kleist P; Ehrlich A; Wieckhorst G; Lücker PW; Fuder H
    Methods Find Exp Clin Pharmacol; 1995 Sep; 17(7):489-95. PubMed ID: 8577212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of Acid Secretion by Lansoprazole and its Effects on Helicobacter pylori. II. Poster presentations from the 2nd International Colloquium on Proton Pump Inhibitors. Houston, Texas, September 29, 1994.
    J Clin Gastroenterol; 1995; 20 Suppl 2():S1-135. PubMed ID: 7594319
    [No Abstract]   [Full Text] [Related]  

  • 19. Preformulation investigation of the novel proton pump inhibitor lansoprazole.
    Kristl A; Vrecer F
    Drug Dev Ind Pharm; 2000 Jul; 26(7):781-3. PubMed ID: 10872099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fecal clearance of alpha 1-antitrypsin: a reliable measure of enteric protein loss in children.
    Hill RE; Hercz A; Corey ML; Gilday DL; Hamilton JR
    J Pediatr; 1981 Sep; 99(3):416-8. PubMed ID: 6973619
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.